Transforming Cancer Care: Unlocking Real-World Evidence for Market Access and HTA with Flatiron Health

KB at your finger tips

This is one stop global knowledge base where you can learn about all the products, solutions and support features.

Products-Flatiron Health

Transforming Cancer Care: Unlocking Real-World Evidence for Market Access and HTA with Flatiron Health

Empowering Life Science Partners with Real-World Evidence

Flatiron Health stands at the forefront of oncology real-world evidence, aiding life science partners in conducting critical health economics and outcomes research (HEOR) studies. These studies are particularly crucial in supporting Health Technology Assessments (HTA), essential for accelerating access to cancer treatments globally. With a track record of over 30 HTA submissions, Flatiron data has been recognized as a premier, comprehensive source of oncology data, contributing significantly to assessing comparative effectiveness.

Global Influence and Impact

Flatiron's influence extends across international borders, transforming cancer care and research in major oncology markets such as Japan, Germany, the United Kingdom, and the United States. By expanding its high-quality datasets beyond the US, Flatiron is enabling a global perspective to address pressing questions for patients worldwide. Noteworthy collaborations with HTA bodies like NICE are proving to be instrumental in bridging evidence gaps and informing HTA decisions, bringing real-world data to the forefront of oncology.

Pioneering Research Collaborations

Flatiron's commitment to high-impact research collaborations is evident in its work with esteemed life science partners and HTA bodies. Through innovative collaborations, Flatiron is exploring ways to fill evidence gaps and enhance HTA decision making, ultimately advancing market access for new oncology medicines. The success stories, like the approval of atezolizumab by NICE, underscore the power of comprehensive data packages that leverage Flatiron's reliable data sources.

Driving Market Access and HTA Use Cases

Flatiron's approach to evidence generation is bolstered by its cutting-edge platform, Flatiron Horizon. This platform seamlessly integrates real-world data, cutting-edge technology, proprietary curation methods, and expert insights, reinforcing Flatiron's position as a trusted partner for generating real-world evidence for value and market access decisions. The research insights and resources provided by Flatiron elevate discussions around critical aspects of Health Technology Assessment, offering guidance on transporting comparative effectiveness evidence and addressing key considerations in HTA processes.

Empowering Decision-Making with RWE Consortium

In response to the evolving landscape of oncology and the increasing importance of real-world evidence, Flatiron is spearheading the FLATIRON FORUM. This consortium, aimed at fostering collaboration with global life science companies, seeks to enhance decision-making processes by leveraging exemplar RWE and research methodologies. By facilitating better decision-making through robust evidence, Flatiron is dedicated to expediting patient access to cutting-edge oncology therapies, further cementing its commitment to advancing market access and HTA practices.

Stay Ahead in Today’s Competitive Market!
Unlock your company’s full potential with a Virtual Delivery Center (VDC). Gain specialized expertise, drive seamless operations, and scale effortlessly for long-term success.

Book A Meeting To Setup A VDC

Revolutionizing Clinical Trials with Flatiron Clinical Pipe™

Introduction to Flatiron Clinical Pipe™

Flatiron Clinical Pipe™ is an innovative EHR-to-EDC application that revolutionizes the way clinical trial data is managed. With the ability to capture and transfer both structured and unstructured data with ease, this solution streamlines the entire data collection process. By offering higher data quality and more efficient data management, Flatiron Clinical Pipe™ transforms the clinical trial experience for sponsors, CROs, and clinical trial sites.

Read article

Revolutionizing Oncology Clinical Decision Support with Flatiron Assist™

Empowering Clinicians with Innovative Treatment Insights

Flatiron Assist™ is an EHR-integrated, oncology-specific clinical decision support platform that revolutionizes the way clinicians access and implement evidence-based medicine, clinical research, and site-specific preferences at the point of care. This powerful tool prioritizes the latest treatment guidelines and insights, ensuring that healthcare providers are equipped with the most up-to-date information to optimize patient care.

Read article

Empowering Oncology Research with Real-World Data Solutions from Horizon Datascapes

Tailored Real-World Data Solutions for Oncology Portfolio

Horizon Datascapes, provided by Flatiron Health, offer tailored real-world data solutions to meet the unique needs of oncology portfolios. With over 4 million patient records and 1.5 billion data points, these datasets are designed to address specific use cases efficiently and effectively.

Read article

Revolutionizing Cancer Care: The Impact of Flatiron Health in Oncology Research and Treatment

Who We Are

Flatiron Health is a pioneering healthtech company with a mission to improve and extend lives by learning from the experience of every person with cancer. They believe that this learning process is crucial for accelerating research and enhancing the quality of care in oncology. Their vision is to bridge the gap between care and research using technology and science.

Read article

Revolutionizing Oncology Clinical Trial Recruitment with OncoTrials®

Efficiently match and screen eligible patients

Oncology clinical trial programs are often intricate and multifaceted, presenting a challenge in finding suitable patients for participation. However, with OncoTrials®, this process is simplified and streamlined. Clinical research teams can now swiftly and efficiently assess and confirm eligible trial patients, enhancing the overall recruitment process. By utilizing Electronic Health Record (EHR) data, OncoTrials® enables teams to view filtered and prioritized patients that are at crucial treatment decision points. This not only builds confidence in patient eligibility but also ensures that no potential participant is overlooked. Additionally, the system offers research badges that identify potential patients at the point of care, facilitating proactive patient recruitment.

Read article

Welcome to Knowledge Base!

KB at your finger tips

Products-Flatiron Health